PubMed:19735549 / 806-1460 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T7	234-421	DRI_Approach	denotes	Six to eight weeks after injections, whole-mount, hematoxylin and eosin, and immunofluorescence staining were performed to evaluate the type and extent of growth of the DCIS-like lesions.
T8	422-653	DRI_Background	denotes	To identify tumor-initiating cells, putative human breast stem/progenitor subpopulations were sorted from MCF10DCIS.COM and SUM-225 with flow cytometry, and their in vivo growth fractions were compared with the Fisher's Exact test.

Id	Subject	Object	Predicate	Lexical cue
T48	56-61	D006801	denotes	human
T50	62-66	CVCL_5552	denotes	DCIS
T49	62-66	D002285	denotes	DCIS
T51	62-66	D002285	denotes	DCIS
T54	79-92	CVCL_5552	denotes	MCF10DCIS.COM
T55	84-88	D002285	denotes	DCIS
T57	84-88	D002285	denotes	DCIS
T59	89-92	CHEBI:17905	denotes	COM
T60	97-104	CVCL_5593	denotes	SUM-225
T61	147-152	D006801	denotes	human
T63	153-157	CVCL_5552	denotes	DCIS
T62	153-157	D002285	denotes	DCIS
T64	153-157	D002285	denotes	DCIS
T65	194-199	10090	denotes	mouse
T66	194-199	D051379	denotes	mouse
T67	208-213	UBERON:0000058	denotes	ducts
T68	226-232	UBERON:0002030	denotes	nipple
T69	284-295	D006416	denotes	hematoxylin
T70	284-295	CHEBI:51686	denotes	hematoxylin
T71	284-295	CHEBI:5601	denotes	hematoxylin
T72	284-295	D006416	denotes	hematoxylin
T73	300-305	1310593	denotes	eosin
T74	300-305	D004801	denotes	eosin
T75	300-305	D004801	denotes	eosin
T77	403-407	CVCL_5552	denotes	DCIS
T76	403-407	D002285	denotes	DCIS
T78	403-407	D002285	denotes	DCIS
T79	434-439	D009369	denotes	tumor
T80	434-439	D009369	denotes	tumor
T81	467-472	D006801	denotes	human
T82	473-479	UBERON:0000310	denotes	breast
T85	528-541	CVCL_5552	denotes	MCF10DCIS.COM
T86	533-537	D002285	denotes	DCIS
T88	533-537	D002285	denotes	DCIS
T90	538-541	CHEBI:17905	denotes	COM
T91	546-553	CVCL_5593	denotes	SUM-225
T93	633-639	76720	denotes	Fisher
T92	633-639	CVCL_E017	denotes	Fisher

Id	Subject	Object	Predicate	Lexical cue
T7	0-233	DRI_Background	denotes	The intraductal models were established by injection of human DCIS cell lines (MCF10DCIS.COM and SUM-225), as well as cells derived from a primary human DCIS (FSK-H7), directly into the primary mouse mammary ducts via cleaved nipple.
T8	234-421	DRI_Approach	denotes	Six to eight weeks after injections, whole-mount, hematoxylin and eosin, and immunofluorescence staining were performed to evaluate the type and extent of growth of the DCIS-like lesions.
T9	422-653	DRI_Approach	denotes	To identify tumor-initiating cells, putative human breast stem/progenitor subpopulations were sorted from MCF10DCIS.COM and SUM-225 with flow cytometry, and their in vivo growth fractions were compared with the Fisher's Exact test.

Id	Subject	Object	Predicate	Lexical cue
T2	0-654	METHODS	denotes	The intraductal models were established by injection of human DCIS cell lines (MCF10DCIS.COM and SUM-225), as well as cells derived from a primary human DCIS (FSK-H7), directly into the primary mouse mammary ducts via cleaved nipple. Six to eight weeks after injections, whole-mount, hematoxylin and eosin, and immunofluorescence staining were performed to evaluate the type and extent of growth of the DCIS-like lesions. To identify tumor-initiating cells, putative human breast stem/progenitor subpopulations were sorted from MCF10DCIS.COM and SUM-225 with flow cytometry, and their in vivo growth fractions were compared with the Fisher's Exact test.